nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesoridazine—DRD3—Gilles de la Tourette syndrome	0.389	0.449	CbGaD
Mesoridazine—DRD2—Gilles de la Tourette syndrome	0.269	0.311	CbGaD
Mesoridazine—HTR2A—Gilles de la Tourette syndrome	0.208	0.24	CbGaD
Mesoridazine—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.0035	0.115	CbGeAlD
Mesoridazine—DRD3—nervous system—Gilles de la Tourette syndrome	0.00159	0.0521	CbGeAlD
Mesoridazine—DRD3—central nervous system—Gilles de la Tourette syndrome	0.00153	0.0502	CbGeAlD
Mesoridazine—HTR6—nervous system—Gilles de la Tourette syndrome	0.00153	0.0502	CbGeAlD
Mesoridazine—HTR6—central nervous system—Gilles de la Tourette syndrome	0.00147	0.0483	CbGeAlD
Mesoridazine—DRD3—brain—Gilles de la Tourette syndrome	0.00121	0.0398	CbGeAlD
Mesoridazine—HTR6—brain—Gilles de la Tourette syndrome	0.00117	0.0383	CbGeAlD
Mesoridazine—HTR2C—midbrain—Gilles de la Tourette syndrome	0.00107	0.0353	CbGeAlD
Mesoridazine—CHRM2—nervous system—Gilles de la Tourette syndrome	0.000916	0.0301	CbGeAlD
Mesoridazine—HTR1A—midbrain—Gilles de la Tourette syndrome	0.000904	0.0297	CbGeAlD
Mesoridazine—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000883	0.029	CbGeAlD
Mesoridazine—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.000882	0.029	CbGeAlD
Mesoridazine—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.00085	0.0279	CbGeAlD
Mesoridazine—DRD2—midbrain—Gilles de la Tourette syndrome	0.000817	0.0268	CbGeAlD
Mesoridazine—KCNH2—midbrain—Gilles de la Tourette syndrome	0.000805	0.0264	CbGeAlD
Mesoridazine—HTR1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.000789	0.00827	CbGpPWpGaD
Mesoridazine—HTR2C—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.000785	0.00822	CbGpPWpGaD
Mesoridazine—DRD2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000766	0.00803	CbGpPWpGaD
Mesoridazine—DRD2—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.000762	0.00799	CbGpPWpGaD
Mesoridazine—DRD3—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000761	0.00797	CbGpPWpGaD
Mesoridazine—HTR2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000754	0.0079	CbGpPWpGaD
Mesoridazine—HRH1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000752	0.00788	CbGpPWpGaD
Mesoridazine—HTR6—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000747	0.00782	CbGpPWpGaD
Mesoridazine—DRD2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000744	0.00779	CbGpPWpGaD
Mesoridazine—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000743	0.0244	CbGeAlD
Mesoridazine—CHRM2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00074	0.00775	CbGpPWpGaD
Mesoridazine—HTR1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000734	0.00768	CbGpPWpGaD
Mesoridazine—HTR2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000732	0.00767	CbGpPWpGaD
Mesoridazine—HRH1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00073	0.00765	CbGpPWpGaD
Mesoridazine—HTR2C—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00073	0.00764	CbGpPWpGaD
Mesoridazine—CHRM2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000719	0.00753	CbGpPWpGaD
Mesoridazine—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000716	0.0235	CbGeAlD
Mesoridazine—HTR1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000712	0.00746	CbGpPWpGaD
Mesoridazine—HTR2C—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000708	0.00742	CbGpPWpGaD
Mesoridazine—CHRM2—brain—Gilles de la Tourette syndrome	0.0007	0.023	CbGeAlD
Mesoridazine—HTR2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.000682	0.00714	CbGpPWpGaD
Mesoridazine—HRH1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00068	0.00713	CbGpPWpGaD
Mesoridazine—HTR2C—brain—Gilles de la Tourette syndrome	0.000675	0.0222	CbGeAlD
Mesoridazine—DRD2—nervous system—Gilles de la Tourette syndrome	0.000672	0.022	CbGeAlD
Mesoridazine—CHRM2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.000669	0.00701	CbGpPWpGaD
Mesoridazine—HTR1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000663	0.00695	CbGpPWpGaD
Mesoridazine—KCNH2—nervous system—Gilles de la Tourette syndrome	0.000662	0.0217	CbGeAlD
Mesoridazine—HTR2C—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00066	0.00691	CbGpPWpGaD
Mesoridazine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000647	0.0212	CbGeAlD
Mesoridazine—DRD2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000644	0.00675	CbGpPWpGaD
Mesoridazine—KCNH2—central nervous system—Gilles de la Tourette syndrome	0.000637	0.0209	CbGeAlD
Mesoridazine—DRD3—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000634	0.00664	CbGpPWpGaD
Mesoridazine—HTR2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000634	0.00664	CbGpPWpGaD
Mesoridazine—HRH1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000632	0.00662	CbGpPWpGaD
Mesoridazine—HTR6—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000628	0.00658	CbGpPWpGaD
Mesoridazine—DRD2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000625	0.00655	CbGpPWpGaD
Mesoridazine—CHRM2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000622	0.00652	CbGpPWpGaD
Mesoridazine—HTR2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000615	0.00644	CbGpPWpGaD
Mesoridazine—HRH1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000614	0.00643	CbGpPWpGaD
Mesoridazine—CHRM2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000604	0.00633	CbGpPWpGaD
Mesoridazine—HTR2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000573	0.006	CbGpPWpGaD
Mesoridazine—HRH1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000572	0.00599	CbGpPWpGaD
Mesoridazine—HTR1A—brain—Gilles de la Tourette syndrome	0.000568	0.0187	CbGeAlD
Mesoridazine—CHRM2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000563	0.00589	CbGpPWpGaD
Mesoridazine—HTR1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000553	0.00579	CbGpPWpGaD
Mesoridazine—HTR2C—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00055	0.00576	CbGpPWpGaD
Mesoridazine—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000539	0.0177	CbGeAlD
Mesoridazine—DRD3—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000533	0.00558	CbGpPWpGaD
Mesoridazine—HRH1—nervous system—Gilles de la Tourette syndrome	0.00053	0.0174	CbGeAlD
Mesoridazine—DRD2—brain—Gilles de la Tourette syndrome	0.000513	0.0169	CbGeAlD
Mesoridazine—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000511	0.0168	CbGeAlD
Mesoridazine—KCNH2—brain—Gilles de la Tourette syndrome	0.000506	0.0166	CbGeAlD
Mesoridazine—DRD2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000485	0.00508	CbGpPWpGaD
Mesoridazine—HRH1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000477	0.00499	CbGpPWpGaD
Mesoridazine—CHRM2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000469	0.00491	CbGpPWpGaD
Mesoridazine—HTR1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000465	0.00487	CbGpPWpGaD
Mesoridazine—HTR2C—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000462	0.00484	CbGpPWpGaD
Mesoridazine—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000443	0.0145	CbGeAlD
Mesoridazine—DRD3—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000432	0.00452	CbGpPWpGaD
Mesoridazine—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000426	0.014	CbGeAlD
Mesoridazine—DRD2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000408	0.00427	CbGpPWpGaD
Mesoridazine—HRH1—brain—Gilles de la Tourette syndrome	0.000405	0.0133	CbGeAlD
Mesoridazine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000404	0.0132	CbGeAlD
Mesoridazine—HRH1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000401	0.0042	CbGpPWpGaD
Mesoridazine—CHRM2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000394	0.00413	CbGpPWpGaD
Mesoridazine—Acetophenazine—DRD2—Gilles de la Tourette syndrome	0.000393	0.0561	CrCbGaD
Mesoridazine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000388	0.0128	CbGeAlD
Mesoridazine—HTR2A—brain—Gilles de la Tourette syndrome	0.000339	0.0111	CbGeAlD
Mesoridazine—HTR2A—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.000335	0.00351	CbGpPWpGaD
Mesoridazine—CHRM2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.000329	0.00344	CbGpPWpGaD
Mesoridazine—HTR2A—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000325	0.00341	CbGpPWpGaD
Mesoridazine—CHRM2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000319	0.00334	CbGpPWpGaD
Mesoridazine—CYP2D6—brain—Gilles de la Tourette syndrome	0.000308	0.0101	CbGeAlD
Mesoridazine—Propiomazine—DRD4—Gilles de la Tourette syndrome	0.000299	0.0427	CrCbGaD
Mesoridazine—Prochlorperazine—DRD3—Gilles de la Tourette syndrome	0.000296	0.0423	CrCbGaD
Mesoridazine—DRD3—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.000282	0.00295	CbGpPWpGaD
Mesoridazine—Cyamemazine—HTR2A—Gilles de la Tourette syndrome	0.000269	0.0383	CrCbGaD
Mesoridazine—Fluphenazine—DRD3—Gilles de la Tourette syndrome	0.000268	0.0383	CrCbGaD
Mesoridazine—Methotrimeprazine—DRD4—Gilles de la Tourette syndrome	0.000256	0.0365	CrCbGaD
Mesoridazine—KCNH2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000254	0.00266	CbGpPWpGaD
Mesoridazine—Triflupromazine—DRD2—Gilles de la Tourette syndrome	0.000241	0.0344	CrCbGaD
Mesoridazine—KCNH2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000232	0.00243	CbGpPWpGaD
Mesoridazine—DRD3—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000229	0.0024	CbGpPWpGaD
Mesoridazine—HTR6—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000228	0.00238	CbGpPWpGaD
Mesoridazine—Acepromazine—DRD2—Gilles de la Tourette syndrome	0.000223	0.0319	CrCbGaD
Mesoridazine—Promazine—DRD4—Gilles de la Tourette syndrome	0.000222	0.0316	CrCbGaD
Mesoridazine—HTR6—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000221	0.00231	CbGpPWpGaD
Mesoridazine—Methotrimeprazine—DRD3—Gilles de la Tourette syndrome	0.000221	0.0315	CrCbGaD
Mesoridazine—Thioproperazine—DRD2—Gilles de la Tourette syndrome	0.000218	0.0311	CrCbGaD
Mesoridazine—Pipotiazine—DRD2—Gilles de la Tourette syndrome	0.000215	0.0306	CrCbGaD
Mesoridazine—Thiothixene—DRD2—Gilles de la Tourette syndrome	0.000215	0.0306	CrCbGaD
Mesoridazine—DRD3—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000213	0.00224	CbGpPWpGaD
Mesoridazine—CHRM2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.000208	0.00218	CbGpPWpGaD
Mesoridazine—HTR6—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000206	0.00216	CbGpPWpGaD
Mesoridazine—Prochlorperazine—DRD2—Gilles de la Tourette syndrome	0.000205	0.0293	CrCbGaD
Mesoridazine—DRD3—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000202	0.00212	CbGpPWpGaD
Mesoridazine—Chlorpromazine—DRD4—Gilles de la Tourette syndrome	0.000195	0.0278	CrCbGaD
Mesoridazine—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000195	0.00204	CbGpPWpGaD
Mesoridazine—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000189	0.00198	CbGpPWpGaD
Mesoridazine—DRD3—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000188	0.00197	CbGpPWpGaD
Mesoridazine—DRD3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000188	0.00197	CbGpPWpGaD
Mesoridazine—Fluphenazine—DRD2—Gilles de la Tourette syndrome	0.000186	0.0265	CrCbGaD
Mesoridazine—HTR1A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000181	0.0019	CbGpPWpGaD
Mesoridazine—DRD2—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000181	0.00189	CbGpPWpGaD
Mesoridazine—Propiomazine—DRD2—Gilles de la Tourette syndrome	0.000178	0.0255	CrCbGaD
Mesoridazine—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000176	0.00185	CbGpPWpGaD
Mesoridazine—HTR1A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000176	0.00185	CbGpPWpGaD
Mesoridazine—DRD2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000175	0.00184	CbGpPWpGaD
Mesoridazine—DRD3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000175	0.00183	CbGpPWpGaD
Mesoridazine—Acepromazine—HTR2A—Gilles de la Tourette syndrome	0.000173	0.0246	CrCbGaD
Mesoridazine—Thioproperazine—HTR2A—Gilles de la Tourette syndrome	0.000169	0.0241	CrCbGaD
Mesoridazine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000168	0.00176	CbGpPWpGaD
Mesoridazine—Chlorpromazine—DRD3—Gilles de la Tourette syndrome	0.000168	0.024	CrCbGaD
Mesoridazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000168	0.00176	CbGpPWpGaD
Mesoridazine—Pipotiazine—HTR2A—Gilles de la Tourette syndrome	0.000166	0.0237	CrCbGaD
Mesoridazine—Thiothixene—HTR2A—Gilles de la Tourette syndrome	0.000166	0.0237	CrCbGaD
Mesoridazine—HTR1A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000164	0.00172	CbGpPWpGaD
Mesoridazine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000163	0.00171	CbGpPWpGaD
Mesoridazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000163	0.0017	CbGpPWpGaD
Mesoridazine—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000161	0.00168	CbGpPWpGaD
Mesoridazine—Thioridazine—DRD2—Gilles de la Tourette syndrome	0.00016	0.0228	CrCbGaD
Mesoridazine—HTR1A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00016	0.00167	CbGpPWpGaD
Mesoridazine—DRD2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000159	0.00167	CbGpPWpGaD
Mesoridazine—DRD2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000155	0.00162	CbGpPWpGaD
Mesoridazine—CHRM2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000154	0.00161	CbGpPWpGaD
Mesoridazine—Methotrimeprazine—DRD2—Gilles de la Tourette syndrome	0.000153	0.0218	CrCbGaD
Mesoridazine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000152	0.0016	CbGpPWpGaD
Mesoridazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000152	0.00159	CbGpPWpGaD
Mesoridazine—Promethazine—DRD2—Gilles de la Tourette syndrome	0.00015	0.0215	CrCbGaD
Mesoridazine—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00015	0.00157	CbGpPWpGaD
Mesoridazine—CHRM2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000149	0.00157	CbGpPWpGaD
Mesoridazine—HTR6—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000148	0.00155	CbGpPWpGaD
Mesoridazine—Trifluoperazine—DRD2—Gilles de la Tourette syndrome	0.000148	0.0212	CrCbGaD
Mesoridazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000148	0.00155	CbGpPWpGaD
Mesoridazine—Perphenazine—DRD2—Gilles de la Tourette syndrome	0.000147	0.0209	CrCbGaD
Mesoridazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000145	0.00152	CbGpPWpGaD
Mesoridazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000145	0.00152	CbGpPWpGaD
Mesoridazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000144	0.00151	CbGpPWpGaD
Mesoridazine—HTR6—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000144	0.00151	CbGpPWpGaD
Mesoridazine—HTR6—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000144	0.00151	CbGpPWpGaD
Mesoridazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000144	0.0015	CbGpPWpGaD
Mesoridazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000144	0.0015	CbGpPWpGaD
Mesoridazine—Fluphenazine—HTR2A—Gilles de la Tourette syndrome	0.000143	0.0205	CrCbGaD
Mesoridazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000143	0.0015	CbGpPWpGaD
Mesoridazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000141	0.00148	CbGpPWpGaD
Mesoridazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000141	0.00148	CbGpPWpGaD
Mesoridazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00014	0.00147	CbGpPWpGaD
Mesoridazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000139	0.00146	CbGpPWpGaD
Mesoridazine—CHRM2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000139	0.00146	CbGpPWpGaD
Mesoridazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000139	0.00145	CbGpPWpGaD
Mesoridazine—Propiomazine—HTR2A—Gilles de la Tourette syndrome	0.000138	0.0197	CrCbGaD
Mesoridazine—HTR2C—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000137	0.00144	CbGpPWpGaD
Mesoridazine—CHRM2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000135	0.00142	CbGpPWpGaD
Mesoridazine—HTR6—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000134	0.00141	CbGpPWpGaD
Mesoridazine—Promazine—DRD2—Gilles de la Tourette syndrome	0.000132	0.0189	CrCbGaD
Mesoridazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000132	0.00138	CbGpPWpGaD
Mesoridazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000131	0.00138	CbGpPWpGaD
Mesoridazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00013	0.00137	CbGpPWpGaD
Mesoridazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00013	0.00136	CbGpPWpGaD
Mesoridazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000129	0.00135	CbGpPWpGaD
Mesoridazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000127	0.00133	CbGpPWpGaD
Mesoridazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000125	0.00131	CbGpPWpGaD
Mesoridazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000124	0.0013	CbGpPWpGaD
Mesoridazine—Thioridazine—HTR2A—Gilles de la Tourette syndrome	0.000124	0.0176	CrCbGaD
Mesoridazine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000123	0.00129	CbGpPWpGaD
Mesoridazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000123	0.00129	CbGpPWpGaD
Mesoridazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000123	0.00129	CbGpPWpGaD
Mesoridazine—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000122	0.00128	CbGpPWpGaD
Mesoridazine—DRD3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000122	0.00128	CbGpPWpGaD
Mesoridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000122	0.00128	CbGpPWpGaD
Mesoridazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000121	0.00127	CbGpPWpGaD
Mesoridazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000121	0.00126	CbGpPWpGaD
Mesoridazine—HRH1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000119	0.00125	CbGpPWpGaD
Mesoridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000119	0.00124	CbGpPWpGaD
Mesoridazine—Methotrimeprazine—HTR2A—Gilles de la Tourette syndrome	0.000118	0.0168	CrCbGaD
Mesoridazine—Chlorpromazine—DRD2—Gilles de la Tourette syndrome	0.000116	0.0166	CrCbGaD
Mesoridazine—Promethazine—HTR2A—Gilles de la Tourette syndrome	0.000116	0.0166	CrCbGaD
Mesoridazine—Trifluoperazine—HTR2A—Gilles de la Tourette syndrome	0.000115	0.0164	CrCbGaD
Mesoridazine—DRD3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000114	0.00119	CbGpPWpGaD
Mesoridazine—Perphenazine—HTR2A—Gilles de la Tourette syndrome	0.000113	0.0162	CrCbGaD
Mesoridazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000113	0.00118	CbGpPWpGaD
Mesoridazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000112	0.00118	CbGpPWpGaD
Mesoridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000111	0.00116	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00011	0.00115	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000109	0.00115	CbGpPWpGaD
Mesoridazine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000107	0.00112	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000107	0.00112	CbGpPWpGaD
Mesoridazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000106	0.00111	CbGpPWpGaD
Mesoridazine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000106	0.00111	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000106	0.00111	CbGpPWpGaD
Mesoridazine—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000105	0.0011	CbGpPWpGaD
Mesoridazine—Promazine—HTR2A—Gilles de la Tourette syndrome	0.000102	0.0146	CrCbGaD
Mesoridazine—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	9.94e-05	0.00104	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	9.89e-05	0.00104	CbGpPWpGaD
Mesoridazine—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.65e-05	0.00101	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.49e-05	0.000994	CbGpPWpGaD
Mesoridazine—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.47e-05	0.000992	CbGpPWpGaD
Mesoridazine—HTR6—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	9.4e-05	0.000985	CbGpPWpGaD
Mesoridazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	9.37e-05	0.000981	CbGpPWpGaD
Mesoridazine—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.37e-05	0.000981	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.32e-05	0.000976	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.22e-05	0.000965	CbGpPWpGaD
Mesoridazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	9.2e-05	0.000963	CbGpPWpGaD
Mesoridazine—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.2e-05	0.000963	CbGpPWpGaD
Mesoridazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.14e-05	0.000957	CbGpPWpGaD
Mesoridazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.09e-05	0.000952	CbGpPWpGaD
Mesoridazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	9.05e-05	0.000948	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.05e-05	0.000948	CbGpPWpGaD
Mesoridazine—Chlorpromazine—HTR2A—Gilles de la Tourette syndrome	8.99e-05	0.0128	CrCbGaD
Mesoridazine—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.58e-05	0.000899	CbGpPWpGaD
Mesoridazine—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.57e-05	0.000897	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.43e-05	0.000883	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.39e-05	0.000879	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.14e-05	0.000853	CbGpPWpGaD
Mesoridazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	8.02e-05	0.000841	CbGpPWpGaD
Mesoridazine—DRD3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.99e-05	0.000836	CbGpPWpGaD
Mesoridazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.88e-05	0.000825	CbGpPWpGaD
Mesoridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.75e-05	0.000812	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.62e-05	0.000798	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.59e-05	0.000795	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.4e-05	0.000775	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.96e-05	0.000729	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.92e-05	0.000725	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.92e-05	0.000725	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.89e-05	0.000722	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.44e-05	0.000675	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.28e-05	0.000658	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.21e-05	0.00065	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.18e-05	0.000647	CbGpPWpGaD
Mesoridazine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.11e-05	0.00064	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.03e-05	0.000631	CbGpPWpGaD
Mesoridazine—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6e-05	0.000628	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6e-05	0.000628	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.9e-05	0.000618	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.85e-05	0.000613	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.64e-05	0.000591	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.62e-05	0.000588	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.61e-05	0.000588	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.59e-05	0.000585	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.47e-05	0.000573	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.45e-05	0.000571	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.45e-05	0.00057	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	5.4e-05	0.000565	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.36e-05	0.000562	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.35e-05	0.000561	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.31e-05	0.000557	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.29e-05	0.000554	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.27e-05	0.000552	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.21e-05	0.000545	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.2e-05	0.000544	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.11e-05	0.000536	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.1e-05	0.000534	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.07e-05	0.000531	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.95e-05	0.000519	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.87e-05	0.00051	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.86e-05	0.000509	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.85e-05	0.000508	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.84e-05	0.000507	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.82e-05	0.000505	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.81e-05	0.000503	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.78e-05	0.000501	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.76e-05	0.000499	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.73e-05	0.000495	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.72e-05	0.000494	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.64e-05	0.000486	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.51e-05	0.000473	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.5e-05	0.000471	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.41e-05	0.000461	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.4e-05	0.00046	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.37e-05	0.000458	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.33e-05	0.000453	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.1e-05	0.000429	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.07e-05	0.000426	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.93e-05	0.000412	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.91e-05	0.00041	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.71e-05	0.000389	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.57e-05	0.000374	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.55e-05	0.000372	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.46e-05	0.000362	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.45e-05	0.000362	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.39e-05	0.000355	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.34e-05	0.000349	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.33e-05	0.000349	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.31e-05	0.000347	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.23e-05	0.000339	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.22e-05	0.000337	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.14e-05	0.000328	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.08e-05	0.000323	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.03e-05	0.000317	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.01e-05	0.000316	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3e-05	0.000314	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.92e-05	0.000306	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.88e-05	0.000301	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.87e-05	0.000301	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.85e-05	0.000299	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.84e-05	0.000297	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.83e-05	0.000296	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.79e-05	0.000293	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.79e-05	0.000292	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.74e-05	0.000287	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.6e-05	0.000273	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.6e-05	0.000272	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.56e-05	0.000268	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.42e-05	0.000254	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.11e-05	0.000221	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.1e-05	0.00022	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.85e-05	0.000194	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.82e-05	0.000191	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.79e-05	0.000187	CbGpPWpGaD
